Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Triapine in new phase II trial with gemcitabine for NSCLC

May 23, 2003

FDA approves Gleevec for Ph+ CML

May 23, 2003

Data safety monitoring board clears phase III Thymitaq trial to continue

May 23, 2003

PI3-kinase modulators with antiproliferative activity reported by Iconix

May 23, 2003

Millennium ships Velcade within a week of FDA approval

May 22, 2003

Kirin identifies new antitumor FGFR inhibitors

May 22, 2003

Sankyo describes new compounds with PPARgamma-agonist and antitumor activity

May 22, 2003

Water-soluble etoposide prodrugs prepared and tested by French research team

May 22, 2003

ExonHit Therapeutics claims novel antitumor compounds in recent patent

May 22, 2003

Bexarotene reported effective in parapsoriasis

May 21, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...